Characteristics and Disease Burden of Patients With Eosinophilic Granulomatosis With Polyangiitis Initiating Mepolizumab in the United States

BACKGROUND/OBJECTIVE: Although the high disease burden associated with eosinophilic granulomatosis with polyangiitis (EGPA) has been established, the disease burden in patients initiating mepolizumab in real-world practice is poorly understood. This study aimed to assess characteristics and burden o...

Descripción completa

Detalles Bibliográficos
Autores principales: Silver, Jared, Deb, Arijita, Packnett, Elizabeth, McMorrow, Donna, Morrow, Cynthia, Bogart, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662597/
https://www.ncbi.nlm.nih.gov/pubmed/37779234
http://dx.doi.org/10.1097/RHU.0000000000002033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662597/
https://www.ncbi.nlm.nih.gov/pubmed/37779234
http://dx.doi.org/10.1097/RHU.0000000000002033

Ejemplares similares